Sabrina Johnson - Aethlon Medical Independent Director
| AEMD Stock | USD 1.53 0.02 1.32% |
Director
Ms. Sabrina Martucci Johnson is Independent Director of the company. Ms. Johnson became a Director of Aethlon Medical, Inc. in January 2018. Ms. Johnson founded Dar Bioscience, Inc., a biopharmaceutical company dedicated to advancement of innovative products for womens reproductive health, in 2015 and has served as its President, Chief Executive Officer and a member of its Board of Directors since its inception. Prior to founding Dar, Ms. Johnson was President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015. Before serving as President of WomanCare Global Trading, Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the forprofit Trading division as well as the United Kingdombased nonprofit division, from November of 2012 to July of 2013, when she joined full time as WomanCares Chief Financial Officer and Chief Operating Officer until becoming President of the Trading division. Ms. Johnson currently serves on the YWCA of San Diego County Board of Directors as Past President, PPPSW Board of Directors, Athena San Diego Board of Directors as Vice Chair, Tulane University School of Science Engineering Board of Advisors, University of California San Diego Librarians Advisory Board as Chair and Project Concern International Audit Committee since 2018.
| Age | 50 |
| Tenure | 6 years |
| Address | 11555 Sorrento Valley Road, San Diego, CA, United States, 92121 |
| Phone | 619 941 0360 |
| Web | https://www.aethlonmedical.com |
Aethlon Medical Management Efficiency
The company has return on total asset (ROA) of (0.4716) % which means that it has lost $0.4716 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9843) %, meaning that it created substantial loss on money invested by shareholders. Aethlon Medical's management efficiency ratios could be used to measure how well Aethlon Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of April 25, 2024, Return On Tangible Assets is expected to decline to -7.73. The current year's Return On Capital Employed is expected to grow to -0.81. At present, Aethlon Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 18.2 M, whereas Intangible Assets are forecasted to decline to 1,411.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bret Hankey | Bone Biologics Corp | 39 | |
| Benjamin Wu | Bone Biologics Corp | 53 | |
| Michael Mashaal | ReShape Lifesciences | 42 | |
| Thomas Mika | NanoVibronix | 64 | |
| Jimmy Delshad | Bone Biologics Corp | 74 | |
| Martin Goldstein | NanoVibronix | 45 | |
| Harold Jacob | NanoVibronix | 59 | |
| Lori McDougal | ReShape Lifesciences | 56 | |
| John Booth | Bone Biologics Corp | 60 | |
| Arda Minocherhomjee | ReShape Lifesciences | N/A | |
| Bobby Griffin | ReShape Lifesciences | 79 | |
| Chia Soo | Bone Biologics Corp | 47 | |
| William Coffin | Bone Biologics Corp | 69 | |
| Michael Ferguson | NanoVibronix | 42 | |
| Gary Blackford | ReShape Lifesciences | 60 | |
| Jon Tremmel | ReShape Lifesciences | 69 | |
Management Performance
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.47 |
Aethlon Medical Leadership Team
Elected by the shareholders, the Aethlon Medical's board of directors comprises two types of representatives: Aethlon Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aethlon. The board's role is to monitor Aethlon Medical's management team and ensure that shareholders' interests are well served. Aethlon Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aethlon Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Chief Officer | ||
| John Marco, IR Contact Officer | ||
| Sabrina Johnson, Independent Director | ||
| James Joyce, Founder, Chairman, CEO and Secretary | ||
| Franklyn Barry, Independent Director | ||
| Timothy Rodell, Interim CEO, Director | ||
| Rodney Kenley, Pres and Director | ||
| Edward Broenniman, Independent Director | ||
| Charles Fisher, Independent Director | ||
| Lee Arnold, Chief Officer | ||
| Chetan Shah, Independent Director | ||
| James MBA, CFO, CEO | ||
| Sunil Sawhney, Head Studies | ||
| Guy Cipriani, Independent Director | ||
| MD Fisher, Director CEO | ||
| Steven MD, Chief Officer | ||
| James Frakes, CFO and Sr. VP of Fin. | ||
| Richard Tullis, Chief Science Officer and VP |
Aethlon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aethlon Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (20.47) % | ||||
| Current Valuation | (3.08 M) | ||||
| Shares Outstanding | 2.63 M | ||||
| Shares Owned By Insiders | 6.43 % | ||||
| Shares Owned By Institutions | 1.98 % | ||||
| Number Of Shares Shorted | 18.92 K | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.52 X |
Pair Trading with Aethlon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Aethlon Stock
| 0.68 | NRC | National Research Corp | PairCorr |
Moving against Aethlon Stock
| 0.6 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.56 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.49 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.46 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.45 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.